Reneo Pharmaceuticals Statistics

Total Valuation

RPHM has a market cap or net worth of $50.47 million. The enterprise value is -$31.46 million.

Market Cap	50.47M
Enterprise Value	-31.46M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

RPHM has 33.42 million shares outstanding. The number of shares has increased by 33.49% in one year.

Shares Outstanding	33.42M
Shares Change (YoY)	+33.49%
Shares Change (QoQ)	-0.38%
Owned by Insiders (%)	5.14%
Owned by Institutions (%)	89.74%
Float	8.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.62
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 29.83, with a Debt / Equity ratio of 0.01.

Current Ratio	29.83
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.80% and return on invested capital (ROIC) is -93.12%.

Return on Equity (ROE)	-67.80%
Return on Assets (ROA)	-60.10%
Return on Capital (ROIC)	-93.12%
Revenue Per Employee	n/a
Profits Per Employee	-$8.84M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.44% in the last 52 weeks. The beta is 0.23, so RPHM's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	-76.44%
50-Day Moving Average	1.68
200-Day Moving Average	3.43
Relative Strength Index (RSI)	37.76
Average Volume (20 Days)	208,570

Short Selling Information

The latest short interest is 3.58 million, so 10.71% of the outstanding shares have been sold short.

Short Interest	3.58M
Short Previous Month	3.50M
Short % of Shares Out	10.71%
Short % of Float	39.87%
Short Ratio (days to cover)	17.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-76.50M
Pretax Income	-70.71M
Net Income	-70.71M
EBITDA	-70.26M
EBIT	-70.71M
Earnings Per Share (EPS)	-$2.18

Full Income Statement

Balance Sheet

The company has $82.84 million in cash and $907,000 in debt, giving a net cash position of $81.93 million or $2.45 per share.

Cash & Cash Equivalents	82.84M
Total Debt	907,000
Net Cash	81.93M
Net Cash Per Share	$2.45
Equity (Book Value)	81.24M
Book Value Per Share	2.43
Working Capital	81.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.65 million and capital expenditures -$49,000, giving a free cash flow of -$75.70 million.

Operating Cash Flow	-75.65M
Capital Expenditures	-49,000
Free Cash Flow	-75.70M
FCF Per Share	-$2.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RPHM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.49%
Shareholder Yield	-33.49%
Earnings Yield	-140.11%
FCF Yield	-150.00%

Analyst Forecast

The average price target for RPHM is $11.46, which is 658.94% higher than the current price. The consensus rating is "Buy".

Price Target	$11.46
Price Target Difference	658.94%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2